Eupraxia Pharmaceuticals Inc. ( EPRX) - Key Metrics
EPRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.22 | -$0.21 | -$0.21 |
| 2026Q1 | $0 | -$0.22 | -$0.18 | -$0.18 |
| 2025Q4 | $0 | -$0.32 | -$0.19 | -$0.19 |
| 2025Q3 | $0 | -$0.14 | -$0.10 | -$0.10 |
| 2025Q2 | $0 | -$0.24 | -$0.23 | -$0.24 |
EPRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.18 |
| 2026Q1 | 0% | -7.87 |
| 2025Q4 | 0% | -5.55 |
| 2025Q3 | 0% | -7.76 |
| 2025Q2 | 0% | -6 |
EPRX
Price: $6.73
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 449.5 million